Aurum Biosciences Ltd
PrivateLast Round
Series A
Jul 11, 2026
Total Funding Raised
$5.43M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aurum Biosciences Ltd is a clinical-stage biopharmaceutical company that develops novel oxygen carriers for use as therapeutics and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurum Biosciences Ltd Comparables
Compare Aurum Biosciences Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolong Pharmaceuticals, LLC | 83% | |
| NuvOx Therapeutics | 80% | |
| Fluoro2 Therapeutics | 76% |
Aurum Biosciences Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 11, 2026 | ||||
| Seed | Jan 24, 2024 | ||||
| VC Round | Oct 12, 2020 | ||||
| Seed | Nov 13, 2015 |
Aurum Biosciences Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InnoScot Health | VC Round, Seed |
| The TRICAPITAL Syndicate | VC Round, Seed |
| Scottish National Investment Bank | VC Round, Seed |
| Scottish Investment Bank (Scottish Enterprise) | VC Round, Seed |
| Wellcome Trust | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 56% MoM.
- Jul 11, 2026
$13M round completed.
Aurum Biosciences Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aurum Biosciences Ltd's valuation, stock price, and market status.
Is Aurum Biosciences Ltd a public or private company?
Aurum Biosciences Ltd is a private company.
What is the current stock price of Aurum Biosciences Ltd?
Aurum Biosciences Ltd is a private company with no public stock price. No recent secondary market data is available.
How much is Aurum Biosciences Ltd worth (valuation)?
Valuation information for Aurum Biosciences Ltd is not publicly available.
Can I buy Aurum Biosciences Ltd stock?
Aurum Biosciences Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aurum Biosciences Ltd's last funding round?
Aurum Biosciences Ltd's most recent funding round was VC Round on January 24, 2024.
Who are the main investors in Aurum Biosciences Ltd?
Key investors in Aurum Biosciences Ltd include InnoScot Health.
Will Aurum Biosciences Ltd IPO soon?
No public IPO plans have been announced for Aurum Biosciences Ltd.
How can I track Aurum Biosciences Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aurum Biosciences Ltd's secondary market activity and sign up for updates.